Profile of Helicobacter pylori infections among children in the South Island of New Zealand (2010–2021)
Helicobacter · 2024
DOI: 10.1111/hel.13037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helicobacter, 2024. Verfasst von Angharad Vernon-Roberts und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University of Otago Christchurch, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Helicobacter pylori is a gram‐negative gut bacterium most often acquired during childhood. International guidelines state that children with suspected H. pylori infection should be referred to a gastroenterologist for investigation via gastroscopy and biopsy. Eradication therapy should be prescribed for children with peptic ulcer disease or following a treatment risk/benefit discussion for those with an incidental gastroscopy finding. Guidelines state that for children a “test‐and‐treat” approach is not warranted, contrasting recommendations for adults. The aim of this study was to profile pediatric H. pylori infections in the South Island of New Zealand (NZ) to determine diagnostic and management strategies, and adherence to international guidelines. Materials and Methods Retrospective data for positive H. pylori tests between 2010 and 2021 were retrieved from hospitals and regional testing laboratories throughout the South Island (NZ) for children ≤18 years. Outcome data were retrieved from tertiary care hospital records; sociodemographic, testing methods, eradication therapy, and symptoms.
Results
Two‐hundred and forty children were identified: 105 (44%) male, mean age 13.2 years (SD 4.3). Participants of Pasifika, Asian, and Middle Eastern/Latin American/African heritage were overrepresented compared to the NZ census data. Overall, 138 (58%) children were diagnosed via stool antigen tests, 78 (32%) serum, and only 24 (10%) adhered to international guidelines in being confirmed via gastroscopy. Only 59 (25%) had a record of eradication therapy, and 39/59 (66%) were retested to determine eradication success, with 32 (82%) negative tests and seven (18%) remaining positive. Of the 181 (75%) that had eradication status unknown, 66 (28%) had a retest result available with 48 (73%) testing negative and 18 (27%) positive, suggesting a substantial proportion had received eradication therapy without adhering to international guidelines.
Conclusions
International guidelines were not adhered to for most children in the study cohort. Implications of this include cost, unnecessary venipuncture, and unjustified antibiotic exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, University of Otago Christchurch, Christchurch, New Zealand.
- Department of Surgery, University of Otago Christchurch, Christchurch, New Zealand.
ORCID-Profile: Angharad Vernon-Roberts
Zitieren
APA
Vernon-Roberts, A., Premaratne, M., Wright, R., Keenan, J. I., & Day, A. S. (2024). Profile of Helicobacter pylori infections among children in the South Island of New Zealand (2010–2021). Helicobacter. https://doi.org/10.1111/hel.13037
Vancouver
Vernon-Roberts A, Premaratne M, Wright R, Keenan JI, Day AS. Profile of Helicobacter pylori infections among children in the South Island of New Zealand (2010–2021). Helicobacter. 2024. doi:10.1111/hel.13037
BibTeX
@article{VernonRoberts2024,
author = {Vernon-Roberts, Angharad and Premaratne, Malshi and Wright, Raewyn and Keenan, Jacqueline I and Day, Andrew S},
title = {Profile of Helicobacter pylori infections among children in the South Island of New Zealand (2010–2021)},
journal = {Helicobacter},
year = {2024},
doi = {10.1111/hel.13037}
}
EUVIMED